News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
On Tuesday, the Food and Drug Administration (FDA) modified its existing standards surrounding the COVID vaccine. READ MORE, ...
The Centers for Disease Control and Prevention now says that kids with no underlying health conditions "may receive" COVID-19 ...
The Associated Press on MSN11d
FDA sets new requirements for COVID vaccines in healthy adults and childrenFederal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
Trump admin's new FDA update limits annual COVID shots to high-risk groups, ending routine access for healthy kids and adults ...
COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual ...
Health Secretary Robert F. Kennedy Jr.’s decision to revoke the Covid vaccine recommendation for pregnant women has raised ...
The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback